Skip to main content
. 2010 May 26;29(1):58. doi: 10.1186/1756-9966-29-58

Figure 2.

Figure 2

Combined results according to sensitivity analysis - Primary outcomes. CI: confidence interval; PFS: progression free survival; OS: overall survival; BEVA: bevacizumab.